Editorials Lipid lowering for primary prevention of stroke in older adults? BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2568 (Published 19 May 2015) Cite this as: BMJ 2015;350:h2568 Article Related content Metrics Responses Peer review Related articles Research Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study Published: 19 May 2015; BMJ 350 doi:10.1136/bmj.h2335 ResearchPrimary prevention with lipid lowering drugs and long term risk of vascular events in older people See more Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE BMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146 David Oliver: What the plan for social care omitted BMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227 Stroke: “striking reductions” are seen in number of people with symptoms seeking help BMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406 NICE recommends implantable monitor to identify atrial fibrillation after stroke BMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133 Thrombectomy can be considered up to 24 hours after onset of stroke, says NICE BMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
